Informações:
Falhas:
ID
14533
Descrição
IFM 99-02 Thalidomide in Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00222053
Link
https://clinicaltrials.gov/show/NCT00222053
Palavras-chave
Versões (1)
- 19/04/2016 19/04/2016 -
Transferido a
19 de abril de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Multiple Myeloma NCT00222053
Eligibility Multiple Myeloma NCT00222053
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma NCT00222053
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Myeloma
Item
de novo myeloma
boolean
C0026764 (UMLS CUI [1])
Durie and salmon classification
Item
according to durie and salmon classification stage ii, iii and stage i with a lytic bone lesion
boolean
C0278722 (UMLS CUI [1])
C02787223 (UMLS CUI [2])
C0278724 (UMLS CUI [3])
C02787223 (UMLS CUI [2])
C0278724 (UMLS CUI [3])
Age
Item
patients from 18 to 65 years old
boolean
C0001779 (UMLS CUI [1])
Beta2microglobulin or del13
Item
beta2microglobulin < 3 mg/l or del13 absent
boolean
C0201910 (UMLS CUI [1])
C1517957 (UMLS CUI [2])
C1517957 (UMLS CUI [2])
Informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Transplantation eligible
Item
eligible for transplantation
boolean
C0040732 (UMLS CUI [1,1])
C0013893 (UMLS CUI [1,2])
C0013893 (UMLS CUI [1,2])
Neurological toxicity
Item
peripheral neurological toxicities
boolean
C0031117 (UMLS CUI [1])
Cardiovascular disease
Item
uncontrolled or severe cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Further malignancies
Item
other malignancy except basocellular carcinoma or figo stage i carcinoma of the cervix
boolean
C0006826 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0007114 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C2216722 (UMLS CUI [2,3])
C0332196 (UMLS CUI [1,2])
C0007114 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C2216722 (UMLS CUI [2,3])
Biphosphonate
Item
patient who received biphosphonate during the last 60 days
boolean
C0012544 (UMLS CUI [1])
Creatinine measurement
Item
renal failure definited as creatinine > 150 µmol/l
boolean
C0201976 (UMLS CUI [1])
Cerebrovascular disorder
Item
patient with obvious vascular cerebral medical history
boolean
C0007820 (UMLS CUI [1])
Bilirubin, asat, alat, pal
Item
liver dysfunction definited as bilirubin > 35 µmol/l or asat, alat, pal > 4n
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C1278131 (UMLS CUI [4])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C1278131 (UMLS CUI [4])
Pulmonary function
Item
respiratory dysfunction
boolean
C0231921 (UMLS CUI [1])
HIV positivity
Item
hiv +
boolean
C0019699 (UMLS CUI [1])
Contraception
Item
patient who refused to use an acceptable barrier method for contraception
boolean
C0700589 (UMLS CUI [1])